AUTHORS
Wenqing Wang, PhD, Martin Arreola2, Abdulvasey Mohammed3, Yujin Moon4, Katja Weinacht, MD, PhD5
AFFILIATIONS
1 Stanford University School of Medicine, Stanford, California, United States
2 Stanford University School of Medicine, Stanford, California, United States
3 Stanford University School of Medicine, Stanford, California, United States
4 Stanford University School of Medicine, Stanford, California, United States
5 Stanford University School of Medicine, Stanford, California, United States
ABSTRACT
Background: Reticular dysgenesis (RD), caused by biallelic loss of adenylate kinase 2 (AK2), is characterized by profound neutropenia and T-cell lymphopenia. We previously showed that AK2-deficient granulocytic progenitors initially engage metabolic checkpoints but later escape this restraint, activate mTOR-dependent anabolic pathways, exhaust essential substrates, and undergo proliferative arrest. Here, we investigated whether the failure of thymopoiesis reflects the same metabolic derangements, or, instead, excessive metabolic restraint.
Methods and Results: We first analyzed single-cell RNA-sequencing data from bone marrow of 2 patients with RD and 9 healthy donors, comparing ribonucleoprotein and anabolic programs across myeloid and T-lineage differentiation. In RD patients, ribosomal activities that became paradoxically elevated during late-stage granulopoiesis remained suppressed throughout maturation of the T-lineage, indicating that neutrophils and T cells reach the same fate through opposite metabolic responses.
Next, we used a mouse model to define cell-intrinsic requirements for Ak2, by competitively transplanting CD45.2+ Ak2fl/fl;Mx1-Cre or Ak2fl/+;Mx1-Cre whole bone marrow with CD45.1+ wild-type bone marrow at a 4:1 ratio, followed by poly(I:C)-induced Ak2 deletion after stable engraftment. After Ak2 deletion, donor-derived myeloid and T-cell reconstitution declined markedly, with maturation arrest of early hematopoietic progenitors and markedly reduced thymic output. Ak2-/- CD45.2+ thymocytes constituted less than 0.2% of thymic CD45+ cells, compared to an average of 80% for control Ak2+/- donor cells, and showed impaired T-lineage commitment with arrest predominantly at the early thymic progenitor (ETP)/double-negative (DN) stage. Nascent protein synthesis, quantified in vivo by O-propargyl-puromycin (OPP) incorporation, sharply increased during progression from ETP to DN2/DN3 and immature single-positive (ISP) stages in control thymocytes, whereas Ak2-deficient thymocytes failed to mount the same response and remained at a low metabolic baseline throughout development.
Unexpectedly, the residual Ak2-deficient CD4 single-positive (SP4) compartment was significantly enriched for CD25+ and/or Foxp3+ thymic regulatory T cells (tTregs). Consistent with preferential tTreg survival under metabolic restraint, human SP4 CD25+ thymocytes displayed lower phospho-S6/S6 ratio than SP4 CD25- conventional T cells, suggesting lower mTOR activities in tTregs. Furthermore, treatment using rapamycin, an mTOR inhibitor, increased tTreg frequencies in Foxp3-GFP mice.
Finally, to validate these findings in the human thymus, we constructed a starvation-associated gene module and queried spatial transcriptomic data from the human thymus cell atlas. Increased starvation patterns correlated with a Treg transcriptional signature, particularly within the thymic medulla.
Conclusions: While myeloid cells energetically overspend, conventional T cells self-starve. Conversely, regulatory T cells thrive on austerity. AK2 deficiency exposes lineage-specific characteristics of metabolic governance. Late myeloid progenitors escape checkpoint control, activate energetically costly anabolic programs, and exhaust essential substrates. Developing conventional T cells, by contrast, engage metabolic restraint so completely that they fail to support the anabolic transition required for thymopoiesis. Regulatory T cells appear uniquely adapted to this austere metabolic state and are selectively favored. Thus, reticular dysgenesis is not a single bioenergetic defect, but a disorder in which divergent lineage-specific responses to the same metabolic stress determine cell fate. These findings identified metabolic scarcity as a potential regulator of thymic Treg development and selection, and as a candidate lever for promoting immune tolerance.
DISCLOSURES
Wenqing Wang, PhD: No relevant conflicts of interest to declare.